Inventor · disambiguated record
Matteo Iannacone
Also filed as: IANNACONE MATTEO
20 granted patents·4 pending applications·568 citations·filing 2008–2022
96Inventor score
Files withMASSACHUSETTS INST TECHNOLOGY8OSPEDALE SAN RAFFAELE SRL4ANTIOS THERAPEUTICS INC3IANNACONE MATTEO3VON ANDRIAN ULRICH H2
Top patents by PatentIndex Score
24 records- 0197US9308280B2Targeting of antigen presenting cells with immunonanotherapeuticsMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Apr 12, 2016·45 cites·23 claims
- 0297US8562998B2Targeting of antigen presenting cells with immunonanotherapeuticsSHI JINJUN·Filed 2009·Granted Oct 22, 2013·44 cites·32 claims
- 0397US8343497B2Targeting of antigen presenting cells with immunonanotherapeuticsBRIGHAM & WOMENS HOSPITAL·Filed 2009·Granted Jan 1, 2013·63 cites·26 claims
- 0497US8343498B2Adjuvant incorporation in immunonanotherapeuticsMASSACHUSETTS INST TECHNOLOGY·Filed 2009·Granted Jan 1, 2013·51 cites·32 claims
- 0596US9474717B2Vaccine nanotechnologyMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Oct 25, 2016·33 cites·12 claims
- 0696US9439859B2Adjuvant incorporation in immunoanotherapeuticsMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Sep 13, 2016·34 cites·24 claims
- 0796US8637028B2Adjuvant incorporation in immunonanotherapeuticsALEXIS FRANK·Filed 2009·Granted Jan 28, 2014·90 cites·34 claims
- 0895US9539210B2Vaccine nanotechnologyMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Jan 10, 2017·27 cites·17 claims
- 0995US9233072B2Adjuvant incorporation in immunonanotherapeuticsMASSACHUSETTS INST TECHNOLOGY·Filed 2012·Granted Jan 12, 2016·27 cites·23 claims
- 1095US8932595B2Nicotine immunonanotherapeuticsIANNACONE MATTEO·Filed 2009·Granted Jan 13, 2015·33 cites·31 claims
- 1195US8277812B2Immunonanotherapeutics that provide IgG humoral response without T-cell antigenIANNACONE MATTEO·Filed 2009·Granted Oct 2, 2012·45 cites·12 claims
- 1294US8906381B2Immunonanotherapeutics that provide IGG humoral response without T-cell antigenIANNACONE MATTEO·Filed 2009·Granted Dec 9, 2014·31 cites·21 claims
- 1393US8591905B2Nicotine immunonanotherapeuticsVON ANDRIAN ULRICH·Filed 2009·Granted Nov 26, 2013·35 cites·25 claims
- 1487US10736848B2Vaccine nanotechnologyVON ANDRIAN ULRICH H·Filed 2008·Granted Aug 11, 2020·4 cites·18 claims
- 1586US11547667B2Vaccine nanotechnologyMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Granted Jan 10, 2023·1 cites·19 claims
- 1683US9526702B2Vaccine nanotechnologyMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Dec 27, 2016·4 cites·21 claims
- 1771US10188733B2Vaccines comprising bisphosphonate and methods of use thereofVON ANDRIAN ULRICH H·Filed 2011·Granted Jan 29, 2019·1 cites·20 claims
- 1856US2023076319A1Inhibitors of hepatitis b virusANTIOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1952US2024000892A1Agents and Methods for Increasing Liver Immune ResponseOSPEDALE SAN RAFFAELE SRL·Filed 2021·Application pending·0 cites
- 2049US11504382B2Tricyclic inhibitors of Hepatitis B virusANTIOS THERAPEUTICS INC·Filed 2019·Granted Nov 22, 2022·0 cites·15 claims
- 2148US12404284B2Spirocyclic inhibitors of hepatitis B virusOSPEDALE SAN RAFFAELE SRL·Filed 2021·Granted Sep 2, 2025·0 cites·17 claims
- 2247US2022251161A1Agents and Methods for Treating Viral InfectionsOSPEDALE SAN RAFFAELE SRL·Filed 2020·Application pending·0 cites
- 2338US2021276967A1Inhibitors of hepatitis b virusOSPEDALE SAN RAFFAELE SRL·Filed 2019·Application pending·0 cites
- 2437US12465590B2Oxalamido-substituted tricyclic inhibitors of hepatitis b virusANTIOS THERAPEUTICS INC·Filed 2020·Granted Nov 11, 2025·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Matteo Iannacone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →